Christine Fox, EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 18,196 shares at $32.46 ($591K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $591k TEVA by EVP, U.S. Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.46 | 9,098 | $295K | 50.0% |
| 2 | $32.46 | 9,098 | $295K | 50.0% |
| Total | $32.46 avg | 18,196 | $591K | 100% |
| Filing → |
| TEVA | SELL | 2025-11-24 | $1.4M | — | Filing → |
| TEVA | SELL | 2025-11-18 | $753K | — | Filing → |
| TEVA | SELL | 2025-03-06 | $161K | — | Filing → |